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Purpose: The surgical robotic system is superior to traditio-
nal laparoscopy in regards to 3-dimensional images and better
instrumentations. Robotic surgery for hepatic resection has not
yet been extensively reported. Patients and Methods: Between
March and May 2007, we performed 3 robot-assisted left
lateral sectionectomies of the liver. Case 1 had a hepatocellular
carcinoma (HCC), case 2 had colon cancer with liver metastasis,
and case 3 had intrahepatic duct stones. Results: All patients
had successful operation and recovered without complications.
Shorter length of hospital stays, earlier start of oral feeding
and less amount of ascites were found. However, case 1 had
recurrent HCC at 3 months after operation. Conclusion:
Robotic-assisted liver surgery is still a new field in its
developing stage. In patients with small malignant tumors and
benign liver diseases, robotic-assisted laparoscopic resection is
feasible and safe. Through experience, the use of robotics is
expected to increase in the treatment of benign diseases and
malignant neoplsms. However, careful patient selection is
important and long-term outcomes need to be evaluated.
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INTRODUCTION
The development of minimally invasive surgery
has led to an increase in laparoscopic hepatic
resection. Particularly for hepatocellular carcinoma
(HCC), in which the possibility of repetitive
operation for tumor recurrence or liver trans-
plantation is high, laparoscopic approach results
in less postoperative adhesion than open abdomi-
nal surgery, decreasing the difficulty of dissection
in future operation.
However, laparoscopy is limited by 2-dimen-
sional imaging and restricted instrument motion.
Advanced computer-enhanced technology has
been developed to overcome these limitations.
The surgical robotic system provides 3-dimen-
sional images, allowing surgeons to operate with
advanced vision. Moreover, the robotic system
utilizes EndoWrist, an instrument with a 360-
degree range of motion.
The da Vinci Surgical System (Intuitive Surgical,
Mountain View, CA, USA) and Zeus system
(Computer Motion, Santa Barbara, CA, USA) have
been the only 2 commercially available robotic
systems. In 2003 Computer Motion was purchased
by Intuitive Surgical, thus leaving only the
daVinci in production.1
There have been few reports discussing the
indications of robotic surgery in hepatobiliary
surgery, and robotic surgery for hepatic resection
has not been extensively reported. We present
herein 3 cases of da Vinci robotic-assisted left
lateral sectionectomy of the liver.
PATIENTS AND METHODS
Between March and May 2007, we performed 3
robot-assisted left lateral sectionectomies of the
liver at the Department of Surgery, Yonsei
University College of Medicine, Seoul, Korea.
Case 1
A 63-year-old female with a 20-year history of
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HBV carrier status was admitted for HCC in liver
segment II. Serum alpha-fetoprotein (AFP) level
was 559.3 IU/mL. The patient had liver cirrhosis
corresponding to Child-Pugh class A, and the
Indocyanine Green retention rate at 15 minutes
(ICG-R 15) was 1.4%. Imaging included CT and
MRI, and hepatic angiography revealed a 2 cm
single mass in Segment II consistent with HCC
(Fig. 1). We performed left lateral sectionectomy
using the da Vinci robotic system.
Case 2
A 70-year-old female presented with a 10-month
history of anal bleeding and tenesmus. Colonos-
copy revealed an ulcerofungating mass in the
rectosigmoid colon, 10 - 15 cm from the anal verge
and adenocarcinoma was confirmed from biopsy.
CT showed an ulcerofungating mass at the
rectosigmoid junction with pericolic fat infiltration
and a 1.5 cm hypodense mass on liver segment III,
which was compatible with metastasis (Fig. 2).
Serum carcinoembryonic antigen (CEA) level was
12.7 ng/mL, and carbohydrate antigen 19 - 9 (CA
19 - 9) level 66.5 U/mL. Simultaneous operation
on the colon and metastatic hepatic lesion was
planned using the da Vinci robotic system.
Case 3
A 59-year-old male with a history of removal of
common bile duct (CBD) stone by endoscopic
retrograde cholangiopancreatography (ERCP) in
2004 presented acute abdominal pain for 3 days.
On admission, total and direct bilirubin was 4.3
and 3.9 mg/dL, respectively, and alkaline phos-
phatase was 267 IU/L. The other laboratory findings
were within the normal limits. Precontrast CT
Fig. 2. CT shows a hypodense, 1.5 cm mass (A) in segment III consistent with metastasis and an ulcerofungating
mass (B) with minimal pericolic fat infiltration at the rectosigmoid junction.
Fig. 1. CT (A) and MRI (B) show a 2 cm mass consistent with HCC in segment II. HCC, hepatocellular carcinoma.
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revealed several radiopaque stones noted in liver
segment II and a 6 mm calcified stone in the distal
CBD. Mild intrahepatic duct dilatation was noted
with moderate CBD dilatation (Fig. 3). Robot-
assisted left lateral sectionectomy following ERCP
removal of CBD stone was planned.
Surgical technique
Under general anesthesia, the patient was placed
in a supine position, and 5 trocars were used.
Pneumoperitoneum to 12 mmHg was established.
A 12-mm trocar for the robotic camera was placed
above or below the umbilicus by the Hassen
method. Three additional 8-mm trocars were
placed at the left upper quadrant (LUQ), epigastric,
and right upper quadrant (RUQ) areas under the
laparoscopic guidance, respectively. A 12-mm
trocar for an assistant was also placed at the LUQ
area. Insertion sites of trocars were slightly different
for each case because of additional procedures.
The 4-arm da Vinci surgical robot system was
brought into position and docked following port
placement. The operator moved to the console to
control the robotic arms. The assistant remained
at the patient's left side to change robotic instru-
ments and perform clipping, stapling, intraopera-
tive ultrasonography, and choledochoscope
through the 12-mm LUQ trocar site.
A 30 robotic camera was used. After exploration˚
of the abdominal cavity, intraoperative ultrasono-
graphy was used to examine the remaining liver
to search for undetectable lesions and obtain
adequate surgical resection margins. The undis-
sected round ligament was used as grips to
effectively retract the liver. The liver was
mobilized by dividing the left triangular ligament
and lesser omentum. Parenchymal division pro-
ceeded from the anterior edge of the liver by
harmonic scalpel and electrocautery (Fig. 4). The
small vessels and bile ducts exposed during
parenchymal dissection were ligated and divided
by clipping. The Glisson's pedicles of segments II
and III were clamped and divided by endo-GIA
or suture technique (Fig. 5). Dissection proceeded
posteriorly to the left hepatic vein trunk, which
was also clamped and divided by endo-GIA.
Pringle's maneuver was not applied.
A closed suction drain catheter was placed in
the subhepatic space. The specimen was placed in
an endoscopic retrieval bag and removed through
a left subcostal mini-laparotomy incision ex-
tending from the port site.
Especially for case 2, we also performed da Vinci-
assisted low anterior resection following hepatic
resection. However, additional port placement
was not required. For case 3, we performed an
intraoperative choledochoscopic exam, lithotripsy
of the CBD stone, and cholangiography following
lateral sectionectomy of the liver and cholecystec-
tomy. The choledochoscopic exam through the left
intrahepatic duct showed a 7 mm stone. The stone
was removed by Forgathy catheter. We confirmed
by cholangiography that there was no stone in the
biliary tree. The left intrahepatic duct was closed
with several interrupted sutures.
Fig. 3. Precontrast CT shows IHD and CBD dilatation with several radiopaque stones in liver segment II (A) and
a 6 mm calcified stone in the distal CBD (B). IHD, intrahepatic duct; CBD, common bile duct.
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RESULTS
Postoperative course and outcomes
Three consecutive patients successfully under-
went laparoscopic robot-assisted left lateral
sectionectomy. Short-term outcomes including
operative factors are shown in Table 1. After
hepatic resection (cases 1 and 3), hospitalization
lasted for 6 days although recovery was observed
at postoperative day 4. A clear liquid diet was
started on postoperative day 1. For case 2,
hospital stay was longer (total 13 days), and the
diet was started later because of combined colon
surgery. During the Postoperative course, all
patients recovered without complication.
Fig. 4. Operative procedures. Intraoperative ultrasonography for detecting other lesions and determining resection
margins (A). Dissection of falciform ligament and ligamentum venosum after detaching the left triangular ligament using
a harmonic scalpel (B and C). Parenchymal dissection using a harmonic scalpel and electrocautery (D).
Fig. 5. Suture for Glissonian pedicle (A) and endo-GIA for division of hepatic vein (B).
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Pathological examination of case 1 demon-
strated a 2.2-cm HCC with capsular invasion
and focal microvessel invasion. The resection
margin was free of carcinoma and the distance
was 0.8 cm. Pathological examination of case 2
showed a metastatic adenocarcinoma of the liver
with free resection margins. Pathological exami-
nation of case 3 showed intrahepatic duct stones
with chronic proliferative cholangitis and ductal
dilatation.
Follow-up outcome
The patient with HCC (case 1) visited the
outpatient clinic 3 months postoperatively with
left hip pain that had persisted for several days.
On evaluation, AFP level was 65151.8 IU/mL, an
increase from 132.09 IU/mL measured on post-
operative day 7. Follow-up CT showed multiple
intrahepatic masses, compatible with recurrent
HCC and tumor thrombi, in the main portal trunk.
Fig. 6. A 3-month follow-up CT showed multiple intrahepatic masses compatible with HCC with tumor thrombi in the
main portal trunk (A). PET scan shows multiple strong F-18 FDG uptakes at the liver and pelvic bone (B and C). HCC,
hepatocellular carcinoma; PET, positron emission tomography.
C
Table 1. Operative and Postoperative Outcomes
Case 1 Case 2 Case 3
Port location camera : infraumbilical
assistant : LPU
cannula : RUQ, LUQ, RPU
camera : supraumbilical
assistant : LUQ
cannula : RUQ, LPU, RPU
camera : supraumbilical
assistant : LPU
cannula : RUQ, LUQ, RPU
Operative time* (min) 380 360 650
Additional procedures da Vinci assisted
Low anterior resection
Choledochoscopic exam
Lithotripsy
Blood loss (mL) 300 700 100
Transfusion (unit) 0 1 0
Hospital stay (days) 6 13 6
Time to start diet
Liguid
Solid
0th day
1st day
3rd day
6th day
1st day
2nd day
Complication None None None
RUQ, Rt. Upper Quadrant; LUQ, Lt. Upper Quadrant; RPU, Rt. Paraumblical; LPU, Lt. Paraumbilical.
*Operative time for liver surgery.
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Positron Emission Tomography (PET) showed
multiple strong uptake of F-18 FDG in the liver
and pelvic bone mainly on the left side. There was
no evidence of peritoneal seeding (Fig. 6). The
patient was referred to a radiation oncologist.
DISCUSSION
Robotic surgery enables the operator to control
the robotic system alone and to perform more
precise and complex operations. The da Vinci
Surgical System provides surgeons with 1)
intuitive translation of the instrument handle to
the tip movement, thus eliminating the mirror-
image effect, 2) visualization with high-quality 3-
dimensional images and stable camera platform,
3) scaling, 4) tremor filtering, 5) coaxial alignment
of eyes, hand, and tooltip images, 6) EndoWrist
with a 360-degree range of motion, 7) comfor-
table, ergonomically ideal operating position, and
8) possibility of remote site surgery.2-4 These
benefits are most evident when used for precise
surgeries in limited spaces. Robotic liver surgery
provides access to fine structures of the liver and
allows surgeons to see delicate blood vessels and
ducts. Three-dimensional vision offers the advan-
tage of improved depth-perception and accuracy.5
Furthermore, the robotic system involves minimal
intraoperative manipulation of the tumor mass,
resulting in less trauma.
Robotic surgery has several limitations: 1) high
cost, 2) inadequate coverage by medical in-
surance, 3) lack of tactile sense, that can impair
surgeons' capacity to make intuitive decisions, 4)
lack of training systems, 5) heavy robotic arms
and equipments, 6) time-consuming set up, and 7)
difficulty in converting to open surgery.2,3,6
Furthermore, the da Vinci system is not attached
to the operating table, requiring undocking to
change table position. When perilous circums-
tances such as massive bleeding occur, the assistant
can compress bleeding focus with laparoscopic
instruments until conversion to open surgery.
Although conversion time can be longer than in
laparoscopic surgery, the difference was quite
small in our simulations. Problems will most likely
be resolved as computer-enhanced technology
continues to develop and surgeons accumulate
experience.
Currently, the da Vinci robotic system is
applied to almost every surgical procedure.
Evaluation of robotic-assisted surgery in other
fields such as prostate cancer or colorectal disease
was proven to be safe and feasible. Oncological
and functional outcomes are promising.4,7-10 In the
laparoscopic era, no randomized clinical trials
have been performed comparing laparoscopy to
open hepatic resection in terms of safety,
feasibility and efficacy. Simillis et al. investigated
laparoscopic versus open hepatic resection for
hepatic neoplasms through a meta-analysis and
concluded that operative blood loss and duration
of hospital stay were significantly reduced after
laparoscopic surgery and that there was no
difference in postoperative adverse events or the
extent of oncological clearance.11 Vibert et al. con-
cluded after 10 years of experience in performing
laparoscopic liver surgery that the results of
laparoscopy are similar to those of laparotomy,
suggesting that laparoscopy approach could be
used for most hepatic surgeries, including major
hepatectomy, for malignancy.12 Moreover, Chang
et al. advocate that laparoscopic left lateral
sectionectomy for benign or malignant neoplasm
is safe and feasible and can be considered as a
routine approach in selected patients.13 However,
there have been few reports about robotic-assisted
hepatic resection.
In our experience, operative time was longer
due to unfamiliarity with robotic instruments and
set-up time. However, the length of time required
will continue to decrease as surgeons become
more familiar with the procedure. In patients with
small malignant tumors and benign diseases,
robotic-assisted laparoscopic resection is feasible.
Furthermore, we expect that accumulating
experience will make it possible to safely perform
other major hepatectomies. We found shorter
length of hospital stays, earlier start of oral
feeding and less amount of ascites after robotic
surgery compared to open surgery for liver
resection.
From the oncologic point of view, the potential
benefits of a minimally invasive approach in
terms of curability, recurrence, and long-term
survival are inconclusive. Nevertheless to perform
anatomical resection with safe resection margins,
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intraoperative laparoscopic ultrasonography is
indispensable and guarantees precise segmental
tumor location and adjacent vascular or biliary
involvement excluding adjunctive lesions.14
Therefore, we performed laparoscopic ultrasono-
graphy on all patients.
In spite of this effort, case 1 had fulminant
intrahepatic recurrent tumors and bone meta-
stasis. Preoperative CT, MRI, and angiography
did not show any signs for early recurrence. The
possibility that robotic surgery contributed to
early recurrence cannot be excluded. However,
the tumor mass was less manipulated compared
to conventional open surgery.
Another concern is that carbon dioxide insuffla-
tion might promote cancer dissemination, port site
metastases, and peritoneal seeding.15,16 However,
there is no definite evidence in the literature to
show that the spread of cancer is increased.15,17 In
spite of the massive intrahepatic disseminated
masses and bony metastasis in case 1, there was
no evidence of peritoneal seeding. Therefore, we
believe that the route of recurrence was hema-
togenous with portal vein tumor thrombi. Intra-
hepatic metastasis by the portal venous system is
probably an important mechanism for intrahepatic
recurrence either from micrometastasis or
dissemination with manipulation of tumor during
hepatectomy.18,19 For patients with poor prognos-
tic factors after resection for HCC, a number of
adjuvant therapies, such as systemic chemotherapy
and radiation therapy, are available.
In conclusion, da Vinci robotic-assisted hepatic
resection can open a new horizon of treatment
strategies and overcome the limitations of
laparoscopic surgery. In the near future, the use
of robotics is expected to increase in the treatment
of benign disease and malignant neoplasm of the
liver as a minimally invasive surgery. Experience
and judicious application of this new technology
are important.
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